EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer

Aleksander Kielbik, Veronika Bahlinger, Christian M Schürch iD, Maria Luisa Barcena, Olesya Vakhrusheva, Anita Thomas, Igor Tsaur, Jonas S Heitmann, Helmut R Salih, Ilona Hagelstein

ImmunoTargets and Therapy · 2026-05 · Volume 15 · 1-19

DOI: 10.2147/itt.s577364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoTargets and Therapy, 2026-05. Verfasst von Aleksander Kielbik und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

B7-H3CD276CD3T cellbispecific antibodyimmunotherapypenile cancer

Autor:innen und Institutionen

  • Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.
  • Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tuebingen, Tuebingen, Germany.
  • Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tuebingen, Tuebingen, Germany.
  • Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany.
  • German Cancer Consortium (DKTK), Partner Site Tuebingen, a Partnership Between DKFZ and University Hospital Tuebingen, Tuebingen, Germany.

ORCID-Profile: Christian M Schürch

Zitieren

APA

Kielbik, A., Bahlinger, V., Schürch, C. M., Barcena, M. L., Vakhrusheva, O., Thomas, A., Tsaur, I., Heitmann, J. S., Salih, H. R., & Hagelstein, I. (2026). B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer. ImmunoTargets and Therapy, Volume 15, 1-19. https://doi.org/10.2147/itt.s577364

Vancouver

Kielbik A, Bahlinger V, Schürch CM, Barcena ML, Vakhrusheva O, Thomas A, et al. B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer. ImmunoTargets and Therapy. 2026;Volume 15:1-19. doi:10.2147/itt.s577364

BibTeX
@article{Kielbik2026,
  author = {Kielbik, Aleksander and Bahlinger, Veronika and Schürch, Christian M and Barcena, Maria Luisa and Vakhrusheva, Olesya and Thomas, Anita and Tsaur, Igor and Heitmann, Jonas S and Salih, Helmut R and Hagelstein, Ilona},
  title = {B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer},
  journal = {ImmunoTargets and Therapy},
  year = {2026},
  volume = {Volume 15},
  pages = {1--19},
  doi = {10.2147/itt.s577364}
}
Kostenlos starten →